You have free access to this content

American Journal of Transplantation

Cover image for American Journal of Transplantation

October 2013

Volume 13, Issue 10

Pages 2511–2779

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      The AJT Report (pages 2511–2512)

      Sue Pondrom

      Version of Record online: 24 SEP 2013 | DOI: 10.1111/ajt.12490

      Chinese health officials have announced a new national program for deceased organ donation. We take a look at some of the specifics of the program and talk to several transplant professionals, soliciting their views on its substance. Also in this issue, we review the status of comprehensive immunosuppression drug coverage legislation.

  2. Literature Watch

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Literature Watch Implications for transplantation (page 2513)

      Daniel Kreisel and Jonathan S. Bromberg

      Version of Record online: 24 SEP 2013 | DOI: 10.1111/ajt.12491

      • image

      Intragraft tertiary lymphoid organs provide a local structural environment where recipient lymphocytes can extravasate and encounter donor alloantigen for the life of the graft.

  3. Editorials

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Angiotensin II Type 1 Receptor Antibodies: Great Expectations? (pages 2515–2516)

      K. Tinckam and P. Campbell

      Version of Record online: 7 AUG 2013 | DOI: 10.1111/ajt.12396

      Newly available commercial assays for angiotensin II type 1 receptor antibodies provide an opportunity for examining the role of non-HLA antibodies in kidney transplantation, but data do not yet support their widespread clinical use. See articles by Giral et al (page 2567) and Taniguchi et al (page 2577).

    2. You have free access to this content
      Hypogammaglobulinemia: Time to Reevaluate? (pages 2517–2518)

      R. K. Avery and E. A. Blumberg

      Version of Record online: 7 AUG 2013 | DOI: 10.1111/ajt.12403

      The authors discuss the meta-analysis by Florescu and colleagues (page 2601), which examines the relationship between hypogammaglobulinemia, infection and survival.

    3. You have free access to this content
      Urinary Biomarkers and Kidney Transplant Rejection: Fine-Tuning the Radar (pages 2519–2521)

      T. R. Srinivas and B. Kaplan

      Version of Record online: 5 SEP 2013 | DOI: 10.1111/ajt.12427

      This editorial addresses the promise of urinary biomarkers in refining the diagnosis of acute rejection and their potential clinical utility. See article by Hricik et al on page 2634.

    4. You have free access to this content
      Eosinophil-Targeted Therapy: Not the Panacea for Antibody-Mediated Rejection? (pages 2522–2523)

      J. Kers and S. Florquin

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12402

      The study of Cravedi et al (page 2696) challenges the hypothesis that eosinophils are an essential component of the long-lived plasma cells niche in the bone marrow, and it suggests that the role of eosinophils in long-lived plasma cells survival might be mice strain-dependent.

  4. Minireview

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Biological Implications of Extracellular Adenosine in Hepatic Ischemia and Reperfusion Injury (pages 2524–2529)

      M. A. Zimmerman, I. Kam, H. Eltzschig and A. Grenz

      Version of Record online: 7 AUG 2013 | DOI: 10.1111/ajt.12398

      • image

      Targeting extracellular adenosine signaling pathways may prove to be a viable treatment strategy for liver ischemia and reperfusion injury.

  5. Original Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. Basic Science

      You have free access to this content
      Immune Cell-Derived C3a and C5a Costimulate Human T Cell Alloimmunity (pages 2530–2539)

      P. Cravedi, J. Leventhal, P. Lakhani, S. C. Ward, M. J. Donovan and P. S. Heeger

      Version of Record online: 6 SEP 2013 | DOI: 10.1111/ajt.12405

      • image
      • image
      • image
      • image
      • image
      • image

      This study shows that APC-derived C3a and C5a transmit costimulatory, proliferative signals upon ligating their receptors expressed on human alloreactive CD4 T cells, and that pharmacological C5a receptor blockade reduces human, T cell-mediated, xenogeneic graft versus host disease in vivo.

    2. You have free access to this content
      Increased T Cell Glucose Uptake Reflects Acute Rejection in Lung Grafts (pages 2540–2549)

      D. L. Chen, X. Wang, S. Yamamoto, D. Carpenter, J. T. Engle, W. Li, X. Lin, D. Kreisel, A. S. Krupnick, H. J. Huang and A. E. Gelman

      Version of Record online: 8 AUG 2013 | DOI: 10.1111/ajt.12389

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Positron emission tomography in combination with flow cytometric analysis reveals that graft resident T cells drive glucose utilization in acutely rejecting mouse lungs.

    3. You have free access to this content
      Correction of Diabetes Mellitus by Transplanting Minimal Mass of Syngeneic Islets Into Vascularized Small Intestinal Segment (pages 2550–2557)

      Z. Kakabadze, S. Gupta, A. Pileggi, R. D. Molano, C. Ricordi, G. Shatirishvili, G. Loladze, K. Mardaleishvili, M. Kakabadze and E. Berishvili

      Version of Record online: 6 SEP 2013 | DOI: 10.1111/ajt.12412

      • image
      • image
      • image
      • image

      Syngeneic transplantation of minimal mass pancreatic islet grafts into an isolated venous sac in diabetic rats is followed by successful engraftment and function with restoration of euglycemia.

    4. You have free access to this content
      Induction of Cardiac Allograft Tolerance Across a Full MHC Barrier in Miniature Swine by Donor Kidney Cotransplantation (pages 2558–2566)

      M. L. Madariaga, S. G. Michel, M. Tasaki, V. Villani, G. M. La Muraglia II, S. Sihag, J. Gottschall, E. A. Farkash, A. Shimizu, J. S. Allan, D. H. Sachs, K. Yamada and J. C. Madsen

      Version of Record online: 22 AUG 2013 | DOI: 10.1111/ajt.12423

      • image
      • image
      • image
      • image
      • image
      • image

      Cotransplantation of heart and kidney grafts in MHC-disparate miniature swine recipients treated with 12 days of high-dose tacrolimus leads to tolerance of both allografts.

    5. Clinical Science

      You have free access to this content
      Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss (pages 2567–2576)

      M. Giral, Y. Foucher, A. Dufay, J. P. D. Van Huyen, K. Renaudin, A. Moreau, A. Philippe, B. Hegner, R. Dechend, H. Heidecke, S. Brouard, A. Cesbron, S. Castagnet, A. Devys, J. P. Soulillou and D. Dragun

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12397

      • image
      • image
      • image

      The authors find that a high serum level of anti-angiotensin II type 1 receptor antibodies in kidney transplant recipients before transplantation is an independent risk factor for long-term graft loss in association with a higher risk of early acute rejection episodes. See related paper by Taniguchi et al (page 2577) and editorial by Tinckam and Campbell (page 2515).

    6. You have free access to this content
      Higher Risk of Kidney Graft Failure in the Presence of Anti-Angiotensin II Type-1 Receptor Antibodies (pages 2577–2589)

      M. Taniguchi, L. M. Rebellato, J. Cai, J. Hopfield, K. P. Briley, C. E. Haisch, P. G. Catrou, P. Bolin, K. Parker, W. T. Kendrick, S. A. Kendrick, R. C. Harland and P. I. Terasaki

      Version of Record online: 13 AUG 2013 | DOI: 10.1111/ajt.12395

      • image
      • image
      • image
      • image
      • image

      This study examines the association of non-HLA antibodies against angiotensin II type 1 receptor with kidney allograft failure, showing the higher frequency of those antibodies in biopsy-abnormal patients and also showing the independent association of de novo antibodies with graft failure. See related paper by Giral et al (page 2567) and editorial by Tinckam and Campbell (page 2515).

    7. You have free access to this content
      Polyreactive Antibodies Developing Amidst Humoral Rejection of Human Kidney Grafts Bind Apoptotic Cells and Activate Complement (pages 2590–2600)

      F. Porcheray, J. W. Fraser, B. Gao, A. McColl, J. DeVito, I. Dargon, Y. Helou, W. Wong, T. C. Girouard, S. L. Saidman, R. B. Colvin, A. Palmisano, U. Maggiore, A. Vaglio, R. N. Smith and E. Zorn

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12394

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      The authors show that antibody-mediated rejection is accompanied by the development of serum polyreactive antibodies that bind apoptotic cells and activate complement, potentially triggering C4d deposition in damaged graft tissues.

    8. You have free access to this content
      What Is the Impact of Hypogammaglobulinemia on the Rate of Infections and Survival in Solid Organ Transplantation? A Meta-Analysis (pages 2601–2610)

      D. F. Florescu, A. C. Kalil, F. Qiu, C. M. Schmidt and U. Sandkovsky

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12401

      • image
      • image
      • image

      Severe hypogammaglobulinemia during the first year posttransplantation increases the risk of CMV, fungal and respiratory infections, and it is associated with higher one-year all-cause mortality. See editorial by Avery and Blumberg on page 2517.

    9. You have free access to this content
      Reducing Infection Transmission in Solid Organ Transplantation Through Donor Nucleic Acid Testing: A Cost-Effectiveness Analysis (pages 2611–2618)

      J. C. Lai, J. G. Kahn, M. Tavakol, M. G. Peters and J. P. Roberts

      Version of Record online: 22 AUG 2013 | DOI: 10.1111/ajt.12429

      • image
      • image

      Using cost-effectiveness analyses, the authors compare donor nucleic acid versus antibody testing for HIV and HCV to reduce infection transmission in solid organ transplantation.

    10. You have free access to this content
      Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients (pages 2619–2633)

      C. J. Clancy, L. Chen, R. K. Shields, Y. Zhao, S. Cheng, K. D. Chavda, B. Hao, J. H. Hong, Y. Doi, E. J. Kwak, F. P. Silveira, R. Abdel-Massih, T. Bogdanovich, A. Humar, D. S. Perlin, B. N. Kreiswirth and M. Hong Nguyen

      Version of Record online: 6 SEP 2013 | DOI: 10.1111/ajt.12424

      • image
      • image
      • image
      • image

      This study describes long-term outcomes of organ transplant recipients with bacteremia due to carbapenem-resistant Klebsiella pneumoniae and evaluates the genetic profiles of infecting strains.

    11. You have free access to this content
      Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury (pages 2634–2644)

      D. E. Hricik, P. Nickerson, R. N. Formica, E. D. Poggio, D. Rush, K. A. Newell, J. Goebel, I. W. Gibson, R. L. Fairchild, M. Riggs, K. Spain, D. Ikle, N. D. Bridges, P. S. Heeger and for the CTOT-01 consortium

      Version of Record online: 22 AUG 2013 | DOI: 10.1111/ajt.12426

      • image
      • image
      • image

      In this multicenter observational study of 280 kidney transplant recipients, the investigators determine that, among multiple urinary mRNA and protein biomarkers studied, results of urinary CXCL9 protein ELISAs best identify patients at the lowest risk for ongoing and/or incipient immune-mediated allograft injury. See editorial by Srinivas and Kaplan on page 2519.

    12. You have free access to this content
      Donor Cancer Transmission in Kidney Transplantation: A Systematic Review (pages 2645–2652)

      D. Xiao, J. C. Craig, J. R. Chapman, B. Dominguez-Gil, A. Tong and G. Wong

      Version of Record online: 26 AUG 2013 | DOI: 10.1111/ajt.12430

      • image
      • image
      • image

      The authors conduct an systematic review of published cases of donor-transmitted cancer and report survival outcomes of recipients by cancer type.

    13. You have free access to this content
      Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney Transplantation (pages 2653–2663)

      P. Perrin, S. Caillard, R. M. Javier, L. Braun, F. Heibel, C. Borni-Duval, C. Muller, J. Olagne and B. Moulin

      Version of Record online: 26 AUG 2013 | DOI: 10.1111/ajt.12425

      • image
      • image
      • image
      • image
      • image

      This longitudinal study analyzes mineral and bone disorders after kidney transplantation and identifies persistent hyperparathyroidism as a risk factor for fractures.

    14. You have free access to this content
      Metabolic Assessment Prior to Total Pancreatectomy and Islet Autotransplant: Utility, Limitations and Potential (pages 2664–2671)

      R. Lundberg, G. J. Beilman, T. B. Dunn, T. L. Pruett, S. C. Chinnakotla, D. M. Radosevich, R. P. Robertson, P. Ptacek, A. N. Balamurugan, J. J. Wilhelm, B. J. Hering, D. E. R. Sutherland, A. Moran and M. D. Bellin

      Version of Record online: 7 AUG 2013 | DOI: 10.1111/ajt.12392

      • image
      • image

      In adult patients with chronic pancreatitis undergoing total pancreatectomy and islet autotransplant, the authors show that metabolic testing performed prior to transplant is modestly helpful in predicting which patients are likely to have at least a moderate islet mass isolated for transplant.

    15. You have free access to this content
      Preventive Intervention for Living Donor Psychosocial Outcomes: Feasibility and Efficacy in a Randomized Controlled Trial (pages 2672–2684)

      M. A. Dew, A. F. DiMartini, A. J. DeVito Dabbs, A. Zuckoff, H. P. Tan, M. L. McNulty, G. E. Switzer, K. R. Fox, J. B. Greenhouse and A. Humar

      Version of Record online: 7 AUG 2013 | DOI: 10.1111/ajt.12393

      • image
      • image
      • image
      • image
      • image

      A single-site clinical trial provides promising early evidence that a brief intervention offered to living kidney donors and living liver donors before surgery can prevent postdonation psychological distress, somatic complaints and donation-related family problems.

    16. You have free access to this content
      Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study (pages 2685–2695)

      M. R. Baldwin, E. R. Peterson, I. Easthausen, I. Quintanilla, E. Colago, J. R. Sonett, F. D'Ovidio, J. Costa, J. M. Diamond, J. D. Christie, S. M. Arcasoy and D. J. Lederer

      Version of Record online: 26 AUG 2013 | DOI: 10.1111/ajt.12428

      • image
      • image
      • image
      • image
      • image

      Lung transplantation using lungs from donors 55 to 64 years old may be safe for adult candidates without a high Lung Allocation Score, and the use of lungs from pediatric donors is associated with a small increase in early graft failure.

  6. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Eosinophils Are Not Required for the Induction and Maintenance of an Alloantibody Response (pages 2696–2702)

      P. Cravedi, D. A. Lessman and P. S. Heeger

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12404

      • image
      • image
      • image
      • image
      • image

      In contrast to a previously reported requirement for eosinophils in the maintenance of plasma cells reactive to nominal antigens, this transplant study performed in eosinophil-deficient mice unexpectedly indicates that eosinophils are not required for the induction and/or maintenance of donor reactive alloantibodies. See editorial by Kers and Florquin on page 2522.

    2. You have free access to this content
      Optimizing Recovery, Utilization and Transplantation Outcomes for Kidneys From Small, ≤20 kg, Pediatric Donors (pages 2703–2712)

      D. G. Maluf, R. J. Carrico, J. D. Rosendale, R. V. Perez and S. Feng

      Version of Record online: 6 SEP 2013 | DOI: 10.1111/ajt.12410

      • image
      • image
      • image

      Using the OPTN database, the authors find an optimal balance between the number versus the outcome of transplants by studying single and en bloc kidney transplants from small pediatric donors (≤20 kg) by single kg weight strata, identifying recovery and utilization patterns, and delineating factors including transplant center experience associated with one-year graft survival.

    3. You have free access to this content
      Written Informed Consent for Living Kidney Donors: Practices and Compliance With CMS and OPTN Requirements (pages 2713–2721)

      C. Thiessen, Y. A. Kim, R. Formica, M. Bia and S. Kulkarni

      Version of Record online: 10 SEP 2013 | DOI: 10.1111/ajt.12406

      • image
      • image

      Although nearly all US transplant centers now obtain written consent for evaluation of living kidney donors, most centers utilize consent documents that do not include all informational elements required by the Centers for Medicare & Medicaid Services or the Organ Procurement and Transplantation Network.

    4. You have free access to this content
      Pilot Study Exploring Lung Allograft Surfactant Protein A (SP-A) Expression in Association With Lung Transplant Outcome (pages 2722–2729)

      F. D'Ovidio, H. Kaneda, C. Chaparro, M. Mura, D. Lederer, S. Di Angelo, H. Takahashi, C. Gutierrez, M. Hutcheon, L. G. Singer, T. K. Waddell, J. Floros, M. Liu and S. Keshavjee

      Version of Record online: 5 SEP 2013 | DOI: 10.1111/ajt.12407

      • image
      • image
      • image

      This study shows that low expression, prior to implantation, of donor lung innate immunity molecule surfactant protein SP-A, with varying levels according to the gene polymorphisms, is associated with the recipient's post-lung transplant clinical outcome.

      Corrected by:

      Erratum: Erratum

      Vol. 14, Issue 2, 496, Version of Record online: 28 JAN 2014

  7. Case Reports

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Fatal Cardiac and Renal Allograft Rejection With Lenalidomide Therapy for Light-Chain Amyloidosis (pages 2730–2733)

      D. E. Meyers, B. Adu-Gyamfi, A. M. Segura, L. M. Buja, H. R. Mallidi, O. H. Frazier and L. Rice

      Version of Record online: 5 AUG 2013 | DOI: 10.1111/ajt.12391

      • image

      The authors report the case of a 68-year-old woman who underwent a successful combined heart and kidney transplant for amyloidosis, was then started on lenalidomide therapy, and died 2 weeks later, likely because of lenalidomide-related severe rejection of both organs.

    2. You have free access to this content
      Reversibility of Acquired Amyloid Polyneuropathy After Liver Retransplantation (pages 2734–2738)

      T. M. Antonini, P. Lozeron, C. Lacroix, Z. Mincheva, A. Durrbach, M. Slama, E. Vibert, D. Samuel and D. Adams

      Version of Record online: 5 AUG 2013 | DOI: 10.1111/ajt.12378

      • image
      • image

      The authors describe the case of a 72-year-old patient with recovery from acquired amyloid neuropathy following retransplantation with a deceased donor 7 years after domino liver transplantation performed for end-stage liver disease.

    3. You have free access to this content
      Native Portal Vein Embolization for Persistent Hyperoxaluria Following Kidney and Auxiliary Partial Liver Transplantation (pages 2739–2742)

      N. Elias, T. Kawai, D. S. C. Ko, R. Saidi, N. Tolkoff-Rubin, S. Wicky, A. B. Cosimi and M. Hertl

      Version of Record online: 5 AUG 2013 | DOI: 10.1111/ajt.12381

      • image
      • image

      In auxiliary partial liver transplantation, native portal vein embolization is demonstrated to increase the auxiliary partial liver graft to native liver mass ratio if the graft provides insufficient liver mass for cure of the metabolic liver disease.

    4. You have free access to this content
      Algorithm for Total Face and Multiorgan Procurement From a Brain-Dead Donor (pages 2743–2749)

      P. S. Brazio, R. N. Barth, B. Bojovic, A. H. Dorafshar, J. P. Garcia, E. N. Brown, S. T. Bartlett and E. D. Rodriguez

      Version of Record online: 5 AUG 2013 | DOI: 10.1111/ajt.12382

      • image
      • image
      • image

      The authors detail a full-face and thoracoabdominal organ procurement and present an algorithm for “face first, concurrent completion” that ensures the integrity of all organs by coordinating multiple surgical teams based on continual reassessment of donor status.

    5. You have free access to this content
      A Four-Year Pathology Review of the Near Total Face Transplant (pages 2750–2764)

      W. Bergfeld, A. Klimczak, J. S. Stratton and M. Z. Siemionow

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12379

      • image
      • image
      • image
      • image

      A four-year follow-up of the near total face transplant suggests that the diagnosis of acute facial allograft rejection is determined by both clinical and histological changes within skin and mucosa components of the graft.

  8. Reports From the CDC: MMWR

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Updated Recommendations for Use of VariZIG—United States, 2013 (pages 2765–2767)

      Version of Record online: 24 SEP 2013 | DOI: 10.1111/ajt.12477

      VariZIG (varicella zoster immune globulin) is indicated for transplant recipients with a significant exposure to varicella who do not have demonstrated immunity to this virus.

  9. Images in Transplantation

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. CME

      You have free access to this content
      Dialysis-Associated Steal Syndrome (pages 2768–2770)

      N. Cyrus, C. Kim, A. Arvelakis and O. R. Colegio

      Version of Record online: 24 SEP 2013 | DOI: 10.1111/ajt.12348

      • image
      • image
  10. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      5 Years After Tragedy: An Update on Organ Procurement Travel in Michigan (pages 2771–2772)

      K. H. Sheetz, W. J. Kanitz, M. J. Englesbe and S. A. Waits

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12399

    2. You have free access to this content
      Successful Treatment of Chronic HCV Infection Should Not Preclude Kidney Donation to an HCV Negative Recipient (pages 2773–2774)

      J. M. Cruzado, S. Gil-Vernet, J. Castellote, O. Bestard, E. Melilli and J. M. Grinyó

      Version of Record online: 6 AUG 2013 | DOI: 10.1111/ajt.12400

    3. You have free access to this content
      Stent Placement for Treating IVC Stenosis Following “Left at Right” Adult Liver Transplantation (pages 2775–2776)

      S. Mizuno, K. Yamakado, A. Tanemura, N. Kuriyama, M. Kishiwada, H. Sakuma and S. Isaji

      Version of Record online: 6 SEP 2013 | DOI: 10.1111/ajt.12415

      • image
    4. You have free access to this content
  11. Errata

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireview
    6. Original Articles
    7. Brief Communications
    8. Case Reports
    9. Reports From the CDC: MMWR
    10. Images in Transplantation
    11. Letters to the Editor
    12. Errata
    1. You have free access to this content
      Erratum (page 2779)

      Version of Record online: 24 SEP 2013 | DOI: 10.1111/ajt.12489

      This article corrects:

      Jaundice Six Months Following Liver Transplantation

      Vol. 13, Issue 4, 1106–1108, Version of Record online: 30 MAR 2013

SEARCH

SEARCH BY CITATION